NVNO Earnings

Quarterly EPS
$-12.25
Q3 2024
$-10.70
Q4 2024
$-7.75
Q1 2025
$-11.52
Q2 2025
$-8.05
Q3 2025
$0.00
Q4 2025
$-5.89
Q1 2026
$-5.37
Q2 2026
Latest RevenueN/A
Latest Net Income-3600000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$5.370-3600000+53.4%
Q1 2026-$5.890-3849000+24.0%
Q4 20250-3736000
Q3 2025-$8.050-4539000+34.3%
Q2 2025-$11.520-6694000-6.2%
Q1 2025-$7.750-4503000+28.6%
Q4 2024-$10.700-6229000+16.1%
Q3 2024-$12.250-5642000+22.2%
Q2 2024-$10.850-4956000
Q1 2024-$10.850-4992000
Q4 2023-$12.750-5649000
Q3 2023-$15.750-5001000
enVVeno Medical (NVNO) — Earnings